Dr. Abdelhakim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Shawnee Mission Pkwy Ste 210
KU Cancer Center Mailstop 5003
Westwood, KS 66205Phone+1 913-588-0348Fax+1 913-588-4085
Education & Training
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
- University of Kansas School of MedicineResidency, Internal Medicine, 2013 - 2016
- Zagazig University Faculty of MedicineClass of 2010
Certifications & Licensure
- KS State Medical License 2020 - 2025
- MO State Medical License 2022 - 2025
- OH State Medical License 2014 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsFavorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation.Joe S Al-Ramahi, Moazzam Shahzad, Andrea Nguyen, Kevin Li, Muhammad Kashif Amin
Bone Marrow Transplantation. 2024-01-01 - 39 citationsImpact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Mary Luder, Nausheen Ahmed
Transplantation and Cellular Therapy. 2021-09-01 - 4 citationsResults of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation.Haitham Abdelhakim, Leyla Shune, Sajjad Bhatti, Amy Cantilena, Andrea Baran
Biology of Blood and Marrow Transplantation. 2019-09-01
Lectures
- Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: